Back to today’s briefing

Story perspectives

Gabapentin Doubles Dementia Risk for Younger Users

8/4/2025

50 9

Summary

Story summary

Lower back pain plagues around 25% of Americans, with a staggering 80% encountering it at some point in their lives. Alarmingly, a 2025 study reveals that Gabapentin, a common treatment, may double dementia risk for users under 65, particularly for those juggling more than 12 prescriptions. The implications are serious and warrant attention.

1 of 1

Story summary

Lower back pain plagues around 25% of Americans, with a staggering 80% encountering it at some point in their lives. Alarmingly, a 2025 study reveals that Gabapentin, a common treatment, may double dementia risk for users under 65, particularly for those juggling more than 12 prescriptions. The implications are serious and warrant attention.